Cervomed Inc. reports a Return on Equity (ROE) of -282.94%.

What is CRVO's dividend yield?

Cervomed Inc. offers a dividend yield of 0.00%.

What is CRVO's Quality Score?

Our AI rates CRVO's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CRVO?

Our AI Timing Score for CRVO is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CRVO belong to?

Cervomed Inc. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Cervomed Inc. (CRVO) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

CRVO AI Analysis Summary

Our AI summary for CRVO: Cervomed Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -282.94%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CRVO

Cervomed Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 74

USD 2.81

0.01 (0.36%) Day Change

Watchlist Portfolio Compare Chart

0.42

D/E

-282.9%

ROE

-198.8%

ROA

0.00%

Div Yield

CERVOMED INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.81 Price 0.01 (0.36%) Day Change	NEWS SCORE: 74

CRVO, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	74
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.81
PBV / Sector	2.44 / 44,105.10
Earning Per Share	-3.26

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	1.45 M GREAT
Average 1W Daily Value	0.81 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,437.83 / 97.23
NPM Average (%) / Sector	-577.14 / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-198.75 / 185,260.64
ROA Average (%) / Sector	-149.72 / 36,684.64
ROA Change Average (%) / Sector	64.17 / 422,221.42 GREAT
ROE (%) / Sector	-282.94 / 243,761.81
ROE Average (%) / Sector	-65.73 / 48,758.38
ROE Change Average (%) / Sector	67.86 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 07:59:50
Symbol	CRVO
Name	CERVOMED INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	9.26 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	25.92 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 20 Park Plaza, Boston, MA, United States, 02116

Phone: 617 744 4400

Website: https://www.cervomed.com

Sector: Healthcare >> Biotechnology

Description: CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.